Pharmaceutical manufacturer Bayer will stop selling and distributing the Essure permanent contraceptive device in the United States after December 31st, 2018, the company announced last week.  The product is the only permanent non-surgical form of birth control available in the US and is...

The US Food and Drug Administration (FDA) has taken steps to restrict the sale and distribution of the Essure device, citing the lack of awareness of the risks and benefits among many women opting for this form of contraception as one of its main concerns. “Based on our review of a growing...

A generic version of the contraceptive injection Depo-Provera (medroxyprogesterone), likely to be cheaper than its branded counterpart, will be reintroduced into local pharmacies across the United States, Teva Pharmaceuticals has announced.  Depo-Provera Contraceptive Injection...